ASP Isotopes publishes corporate deck on isotope enrichment expansion, commercialization milestones

• ASP Isotopes set an EBITDA target of more than $300 million in 2031 while outlining plans to scale isotope enrichment capacity, broaden its product portfolio, and lower unit costs.
• Commercial ramp milestones flagged for 2026 include first Silicon-28 shipments around mid-year, initial Carbon-14 shipments targeted for Q3, initial Ytterbium-176 shipments targeted for Q3.
• Helium plans call for Phase 1 nameplate capacity in Q3 2026 from the Virginia Gas Project, with Phase 1 output of about 58 MCF/day of liquid helium and about 2,500 GJ/day of LNG.
• Phase 2 is described at about 900 MCF/day of liquid helium and about 34,000 GJ/day of LNG, with $750 million in conditional senior debt commitments cited for the expansion.
• Advanced nuclear fuel initiatives under QLE include conversion services, enriched U-235 using its enrichment technologies subject to regulatory approvals, and lithium-6 and lithium-7 supply for nuclear applications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief on May 20, 2026, and is solely responsible for the information contained therein.